A dose-dependent pharmacokinetic study on caffeic acid in rabbits after intravenous administration

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 8, 1997, Pages 727-736

  Uang, Yow Shieng ^a   Hsu, Kuang Yang ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caffeic acid; Renal clearance; Renal excretion rate constant

Indexed keywords

CAFFEIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PHARMACOKINETICS; RABBIT; URINARY EXCRETION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; AREA UNDER CURVE; CAFFEIC ACIDS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; RABBITS;

EID: 0030661613     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199711)18:8<727::AID-BDD58>3.0.CO;2-F     Document Type: Article

References (26)

1. C.-B. Cui, Y. Tezuka, T. Kikuchi, H. Nakano, T. Tamaoki and J.-H. Park, Constituents of Fern. Davallia mariesin Moore. I. Isolation and structures of davallialactone and a new flavanone flucuronide. Chem. Pharm. Bull., 38, 3218-3225 (1990).
2. H. F. Stich, The beneficial and hazardous effects of simple phenolic compounds. Mutat. Res., 259, 307-324 (1991).
3. E. Sondheimer, On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch. Biochem. Biophys., 74, 1131-1138 (1958).
4. Y. Hsu, Y. P. Chen and M. Hang, The Chemical Constituents of Oriental Herbs, Vol. 1. Oriental Healing Arts Institute, Taipei, Taiwan, 1982, p. 264.
5. Y. Kimura, H. Okuda, T. Okuda, T. Hatano, I. Agata and S. Arichi, Studies on the activities of tannins and related compounds from medicinal plants and drugs. VII. Effects of extracts of leaves of artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil. Chem. Pharm. Bull., 33, 2028-2034 (1985)
6. T. Okuyama, S. Shibata, M. Hoson, T. Kawada, H. Osada and T. Noguchi, Effect of oriental plant drugs on platelet aggregation: III. Effect of Chinese drug "Xiebai" on human platelet aggregation. Planta Med., 52, 171-175 (1986).
7. C. G. Fraga, V. S. Martino, G. E. Ferraro, J. D. Coussio and A. Boveris, Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol., 36, 717-720 (1987).
8. M.-T. Huang, R. C. Smart, C.-Q. Wong and A. H. Conney, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-o-tetradecanoylphorbol-13-acetate. Cancer Res., 48, 5941-5946 (1988).
9. A. Nahrstedt, M. Albrecht, V. Wray, H. G. Gumbinger, M. John, H. Winterhoff and F. H. Kemper. Structures of compounds with antigonadotropic activity obtained by in vitro oxidation of caffeic acid. Planta Med., 56, 395-398 (1940).
10. M. John, H. G. Gumbinger and H. Winterhoff, Oxidation products of eaffeic acid as model substances for the antigonadotropic activity ol plant extracts. Planta Med., 56, 14-18 (1990).
11. J. Camarasa, E. Escubedo and T. Adzet, Pharmacokinetics of CA in rats by a high- performance liquid chromatography method. J. Pharm. Biomed. Anal., 6, 503-510 (1988).
12. J. H- Lin, Dose-dependent pharmacokinetics: experimental observations and theoretical considerations. Biopharm. Drug Disposit., 15, 1-31 (1994).
13. Y.-S. Uang, F.-L. Kang and K.-Y. Hsu, Determination of caffeic acid in rabbit plasma by high-performance liquid Chromatography. J. Chromatogr. B. 673, 43-49 (1995).
14. C. Shumaker, PKCALC: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev., 17, 331-348 (1986).
15. M. Metzler and D. L. Weiner, PCNONLIN User Guide. Version. 4.0. Statistical Consultants, Lexington, KY, 1992.
16. M. Gibaldi and D. Perrier, Pharmacokinetics. Dekker, New York, 1982, pp. 45-88.
17. K. Yamaoka, T. Nakagawa and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm., 6, 165-175 (1978).
18. J. H. Zar, Biostatistical Analysis. 2nd edn, Prentice-Hall, Englewood Cliffs, NJ. 1984, pp. 206-235.
19. P. Shan, K. K. Midha, S. Dighe, I. J. McGilveray, J. P. Skelly, A. Yacobi, T. Layloff, C. T. Viswanathan, C. E. Cook, R. D. McDowall, K. A. Pittman and S. Spector, Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res., 9, 588-592 (1992).
20. J. R. Lang and S. Bolton, A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry 2. Statistical analyses. J. Pharm. Biomed. Anal., 9, 435-442 (1991).
21. L. Shared and A. B. C. Yu, Applied Biopharmaceutics and Pharmacokinetics, 3rd edn, Prentice- Hall, Englewood Cliffs, NJ. 1993, pp. 61-76.
22. L. Shared and A. B. C. Yu, Applied Biopharmaceutics and Pharmacokinetics, 3rd edn, Prentice- Hall, Englewood Cliffs, NJ. 1993, pp. 375-379.
23. M. Rowland and T. N. Tozer, Clinical Pharmacokinetics Concepts and Applications, 3rd edn, Williams and Wilkins, Media, PA. 1995, pp. 394-423.
24. J. Kawakami, Y. Yamamura, I. Santa, H. Kotaki, K. Uchino, Y. Sawada and T. Iga, Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation. J. Pharm. Sci., 82, 301-305 (1993).
25. L. Shargel and A. B. C. Yu, Applied Biopharmaceutics and Pharmacokinetics, 3rd edn, Prentice- Hall, Englewood Cliffs, NJ. 1993, pp. 270-273.
26. M. Rowland and T. N. Tozer, Clinical Pharmacokinetics: Concepts and Applications, 3rd edn, Williams and Wilkins, Media, PA. 1995, pp. 169-178.